Trial RAVELLO

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

RAVELLO

Full title

Phase-III-Studie mit RegorAfenibVErsus Placebo als Erhaltungstherapie bei RAS wiLd
Typ metastasierendes koLOrektales Karzinom (RAVELLO-Studie)

EudraCT number

2013-005428-41

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Classification	Code	Description
-		Gastrointestinal tumors
-		Colorectal carcinoma

Trial type

Interventional

Blinding type

Double blinded

Phase

III

Status

Trial finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2014-12-31 / Unknown

	Function	Prename	Surname	Organization
	Principal Investigator	VOLKER	HEINEMANN	Keine Organisationseinheit angegeben